Stories

Discover all of the trending stories of Ipsen Group.

Key highlights

Explore more by category

Filter

Period

Filter by

recent search

Sort

Showing: 1 – 10 of 39 stories

 –  – 1 mins read

 – 1 mins read

Fireside Chat: Innovation and Policy Change in Rare Diseases in Europe 

The rare disease community continues to strive for innovative solutions to meet patient needs and ensure no person living with a rare disease is left behind.  


 –  – 2 mins read

 – 2 mins read

Applications now open for the 2023 Golden Ticket Competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our continued partnership with Biolabs, we’re delighted to be offering the brightest mi


 –  – 4 mins read

 – 4 mins read

Understanding the true impact of living with FOP

This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23,


 –  – 1 mins read

 – 1 mins read

Rethinking risk factors this Liver Cancer Awareness Month

Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the impo


 –  – 1 mins read

 – 1 mins read

Ipsen FY/Q4 2022 results–A word from CEO David Loew

Hear what Ipsen CEO David Loew has to say about our strong full year and Q4 2022 results.


1 2 3 4 8

Discover trending stories

23 May 2023 1 mins read
Fireside Chat: Innovation and Policy Change in Rare Diseases

The rare disease community continues to strive for innovative solutions to meet patient needs and ensure no person living with a rare disease is left behind.  

23 May 2023 2 mins read
Applications now open for the 2023 Golden Ticket Competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our continued partnership with Biolabs, we’re delighted to be offering the brightest mi

12 May 2023 4 mins read
Understanding the true impact of living with FOP

This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23,

02 March 2023 1 mins read
Rethinking risk factors this Liver Cancer Awareness Month

Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the impo

09 February 2023 1 mins read
Ipsen FY/Q4 2022 results–A word from CEO David Loew

Hear what Ipsen CEO David Loew has to say about our strong full year and Q4 2022 results.

05 January 2023 2 mins read
J.P. Morgan Conference 2023: Ipsen shares strategy success

Ipsen leaders will attend the J.P. Morgan Healthcare Conference from January 9-12, 2023, in San Francisco, California. This event will bring together biotech companies, clinical researchers, investors and analysts from all over the world to learn about hea

20 December 2022 1 mins read
Living with PBC: The Person Behind the Chart

‘Invisible’ diseases like primary biliary cholangitis (PBC) can be difficult to recognise, diagnose and to manage effectively. Here Prof. Gideon Hirschfield (University of Toronto, Departments of Medicine, Immunology and Medical Sciences) and Robert Mi

03 November 2022 4 mins read
A Life in a Day with FOP: from Empathy to Understanding…

You can never truly understand what it’s like to live with an ultra-rare condition unless you’ve experienced it for yourself. And with this in mind, we recently embarked on a project to help healthcare professionals experience what it’s like to live

02 November 2022 1 mins read
Ipsen anti-corruption system certification renewed in 2022

In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance, a certification organization dedicated to the prevention of corruption. 

27 October 2022 1 mins read
A word from CEO David Loew

“Our growth platforms have delivered strong sales performance, reflecting improving commercial execution and the strength for our portfolio.” CEO David Loew